Faisal Ghiath Sukhtian - 02 Dec 2021 Form 4 Insider Report for Outlook Therapeutics, Inc. (OTLK)

Role
Director
Signature
/s/ Lawrence Kenyon, Attorney-in-Fact
Issuer symbol
OTLK
Transactions as of
02 Dec 2021
Net transactions value
+$25,200
Form type
4
Filing time
02 Dec 2021, 16:08:11 UTC
Previous filing
07 Oct 2021
Next filing
24 Mar 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OTLK Common Stock Purchase $25,200 +18,000 +90% $1.40 38,000 02 Dec 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.